Was Big Pharma Behind Colorado's Rejection of Medical Marijuana for PTSD?

Warning message

The subscription service is currently unavailable. Please try again later.

Washington's voters legalized recreational marijuana the same day that Colorado's did, but so far that state has been far behind Colorado in creating the infrastructure for the new industry.

Far behind in most ways, that is: Last week the Colorado Board of Health again rejected adding Post-Traumatic Stress Disorder to the list of conditions for which medical marijuana can be prescribed, but Washington will be approving PTSD on July 24.

In making its decision, the Colorado board cited a lack of sufficient scientific evidence proving the plant's effective treatment of PTSD — but Sue Sisley begs to differ. She's the Arizona physician who's been researching the effect of marijuana on veterans suffering from PTSD, and had been awarded a $2 million grant from Colorado for a study that's gained the approval of the FDA — but that study continues to be...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.westword.com/news/was-big-pharma-behind-colorados-rejection-of-medical-marijuana-for-ptsd-6940243